Evolving policy with science

See allHide authors and affiliations

Science  03 Mar 2017:
Vol. 355, Issue 6328, pp. 889
DOI: 10.1126/science.aan0509

You are currently viewing the summary.

View Full Text


Albert Schweitzer, physician and Nobel laureate, wrote: “The first step in the evolution of ethics is a sense of solidarity with other human beings.” The evolution of U.S. policy governing heritable human germline modification reflects this observation, and a “Human Genome Editing” consensus study committee of the U.S. National Academy of Sciences and National Academy of Medicine (NAM) concluded last month that clinical trials for heritable editing, under strict regulations, may eventually be permissible for parents hoping to prevent serious diseases in their children.

  • * Human Genome Editing committee co-chairs; this editorial does not necessarily reflect views of the committee or the U.S. National Academies